SCHEMBL5400948

SCHEMBL5400948

O=P(OCc1ccccc1)(OCc1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CETP P11597 3/20 0.46
ALDH1A1 P00352 1/20 0.45
CFTR P13569 1/20 0.45
IDO1 P14902 1/20 0.43
SRC P12931 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LTA4H P09960 1/20 0.42
EPHX2 P34913 1/20 0.42
USP2 O75604 1/20 0.42
PDPK1 O15530 1/20 0.42
MTOR P42345 1/20 0.42
ALPG P10696 1/20 0.42
PTK2B Q14289 1/20 0.42
AGXT P21549 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20710698 0.91 LTA4H (0.52) TSHRL3MBTL1CETPALDH1A1MEN1
SCHEMBL4232124 0.84 NR4A2 (0.56) TSHRCETPALDH1A1MEN1KMT2A
SCHEMBL389123 0.83 TSHR (0.61) TSHRL3MBTL1CETPALDH1A1IDO1
Silver SCHEMBL4232127 0.81 TSHR (0.50) TSHRTDP1CETPALDH1A1KMT2A
SCHEMBL21891867 0.80 TSHR (0.53) TSHRCETPALDH1A1SRCPDPK1
SCHEMBL206609 0.79 TSHR (0.68) TSHRCETPALDH1A1IDO1SRC
SCHEMBL14812949 0.79 TSHR (0.57) TSHRCETPALDH1A1IDO1SRC
SCHEMBL752361 0.79 TSHR (0.68) TSHRCETPALDH1A1CFTRSRC
SCHEMBL21805836 0.79 MEN1 (0.53) TSHRCETPALDH1A1MEN1KMT2A
SCHEMBL4247405 0.78 TSHR (0.55) TSHRCETPALDH1A1IDO1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751503-A Method for preparing aryl phosphonic acid dialkyl ester by one-pot method 苏州凯若利新材料科技有限公司 2025-04-04 CN disclosed
US-7291478-B1 Rapid screening and analysis of present and potential nerve agents and their degradation products THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2007-11-06 US disclosed
EP-1389624-A1 Phosphorous-containing cysteine and serine protease inhibitors CEPHALON, INC. (US) 2004-02-18 EP disclosed
EP-0871454-A4 1998-11-25 EP disclosed
EP-0871454-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1998-10-21 EP disclosed
US-5639732-A FOR TREATING NERVOUS SYSTEM DISORDERS OR AS ANTIINFLAMMATORY AGENT CEPHALON, INC. (US) 1997-06-17 US disclosed
WO-1997003679-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1997-02-06 WO disclosed